Hydroxychloroquine Sulfate #85523
Product Information
Product Usage Information
Hydroxychloroquine Sulfate is supplied as a lyophilized powder. For a 10 mM stock, reconstitute 5 mg of powder in 1.15 ml of water. Working concentrations and length of treatment can vary depending on the desired effect.
Storage
Product Description
| Molecular Weight | 434 g/mol |
| Purity | >98% |
| Molecular Formula | C18H26ClN3O • H2SO4 |
| CAS | 747-36-4 |
| Solubility | Soluble in water at 40 mg/ml. |
Background
Hydroxychloroquine Sulfate is a 4-aminoquinoline derivative of quinine known to sensitize cells to apoptosis (1,2). This small compound is an anti-malaria drug that has been found to be an effective treatment of rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and other rheumatic diseases (3). Current studies exhibit the diverse immunomodulatory effects that Hydroxychloroquine Sulfate can span, including metabolic, cardiovascular, antithrombotic, antineoplastic, and anti-infectious agent modulation. Prospective modes of action include inhibition of lysosome and autophagosome functions, subsequent immune activation, and interference of cytokine production via its ability to inhibit TLR binding and processing (4). Studies have shown that Hydroxychloroquine Sulfate inhibits IFN-β production (IC50 = 25 μM) by disrupting the cGAS/dsDNA complex (5). Hydroxychloroquine Sulfate can inhibit SARS-CoV-2 infection in vitro and the antiviral and anti-inflammatory effects of this compound make it important when studying different viral diseases (6).
- Kim, W.U. et al. (2006) Clin Exp Immunol 144, 503-11.
- Kalia, S. and Dutz, J.P. Dermatol Ther 20, 160-74.
- Olsen, N.J. et al. (2013) Semin Arthritis Rheum 43, 264-72.
- Schrezenmeier, E. and Dörner, T. (2020) Nat Rev Rheumatol 16, 155-66.
- An, J. et al. (2015) J Immunol 194, 4089-93.
- Liu, J. et al. (2020) Cell Discov 6, 16.
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.